Table 5.
Body weight, BMI, waist circumference, ICO, total body fat mass, and total trunk fat mass scores at baseline (W1) and at the end of the study (W16).
| Placebo Group | Supplemented Group | |||||||
|---|---|---|---|---|---|---|---|---|
| W1 | W16 | W1 | W16 | |||||
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | |
| Body weight, kg | 89.3 | (12.2) | 89.1 | (12.5) | 84.5 | (12.6) | 83.2 b* | (12.6) |
| BMI, kg/m2 | 31.6 | (4.0) | 31.5 | (3.9) | 29.3 a | (2.5) | 28.9 b* | (2.8) |
| Waist circumference, cm | 94.2 | (9.7) | 94.6 | (9.3) | 90.7 | (8.8) | 89.6 b* | (9.3) |
| ICO | 0.560 | (0.05) | 0.563 | (0.05) | 0.533 a | (0.04) | 0.526 b* | (0.04) |
| Total body fat mass, kg | 35.2 | (10.4) | 35.2 | (10.8) | 30.5 a | (7.4) | 29.3 b* | (7.9) |
| Total trunk fat mass, kg | 18.1 | (5.4) | 18.1 | (5.9) | 15.7 a | (4.1) | 14.7 b* | (4.2) |
*—An intragroup difference between baseline (W1) and end of the study (W16) at p ≤ 0.05; a,b—intergroup differences at baseline (W1) and at the end of the study (W16) at p ≤ 0.05.